Funding from the Bill & Melinda Gates Foundation will go toward understanding the benefits o novel cap analogs for therapeutic applications.Warsaw, December 8, 2022. ExPLoRNA Therapeutics, a Polish biotech company revolutionizing mRNA vaccines and therapeutics with unprecedented translational efficiency, received…
- ExPLoRNA Therapeutics receives funding to advance its novel mRNA technology
- ExploRNA Therapeutics at the 2022 BIO International Convention
- Join Us for the Upcoming TeaTime Webinar
- Let’s meet in Basel at the LSX RNA Leaders World Congress 2022!
- Thank you for exciting time during 9th International mRNA Health Conference in Berlin
No comments to show.